OpenVSafe by OpenVAERS
Search V-safe

T9H-80408-62758

1 vaccination 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
801 / CO
Registered
2022-07-13
Relationship
Child or adolescent in my care
Guardian
Q2N-15269-43347
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-13
    Registered in v-safe
  2. 2022-07-13
    Dose 1 — Pfizer-BioNTech
  3. 2022-07-13
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-07-14
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-15
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-07-16
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-17
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-18
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-19
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-20
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-07-27
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-03
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-08-10
    Survey response — day 28, dose 1, under 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Positive for COVID.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-08-10
    Report sent to call center — day 28, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  15. 2022-08-11
  16. 2022-08-11
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  17. 2022-08-17
    Health check-in — day 35, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-08-24
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-10-12
    Survey response — 3 months, dose 1, under 3
    MedDRA: Nasopharyngitis, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: She has a cold, mild fever, runny nose.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2023-01-12
    Health check-in — 6 months, dose 1, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-13Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — day 28, dose 1, under 3

2022-08-10

Symptoms: Positive for COVID.

Release 12 (Under 3) — 3 months, dose 1, under 3

2022-10-12

Symptoms: She has a cold, mild fever, runny nose.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…